Neither has been tested in humans, and both carry significant unknowns -- Dihexa with its retracted publication and oncological pathway concerns, PE-22-28 with its untested cognitive effects and potential seizure susceptibility
Biemond P, Swaak AJ, Koster JF
The glucagon component can also cause transient increases in heart rate and blood glucose, effects that do not occur with amylin-based compounds
Chronic Safety Topics Your Clinician Will Want To Monitor Long-term safety questions include possible effects on the pancreas, gallbladder, thyroid, and bone
It does so by facilitating the detoxification and energy production pathways outlined above, but research shows that it also can have an effect on certain immune markers directly